Stay updated on Safety Tolerability in IPF Clinical Trial
Sign up to get notified when there's something new on the Safety Tolerability in IPF Clinical Trial page.
Latest updates to the Safety Tolerability in IPF Clinical Trial page
- CheckyesterdayChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.1%
- Check8 days agoChange DetectedThe type of intervention has been updated from version v2.13.3 to v2.14.0.SummaryDifference0.2%
- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check29 days agoNo Change Detected
- Check37 days agoChange DetectedThe website has been updated from version v2.13.2 to v2.13.3.SummaryDifference0.1%
- Check44 days agoChange DetectedThe website has updated the contact details section for the study, clarifying that it now provides information for individuals who can answer questions about joining the study and includes a reference to the Contacts and Locations section.SummaryDifference3%
- Check58 days agoChange DetectedSeveral key resources related to idiopathic pulmonary fibrosis have been removed, including links to MedlinePlus and NIH, which may impact access to important information on the condition.SummaryDifference5%
- Check66 days agoChange DetectedNew resources related to idiopathic pulmonary fibrosis and general genetics have been added, including links to MedlinePlus and NIH, enhancing access to information on rare diseases.SummaryDifference0.4%
Stay in the know with updates to Safety Tolerability in IPF Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety Tolerability in IPF Clinical Trial page.